Biosimilar Newsletter Archive

41. 06.29.23 -- Improving Digital Integration Between Biomanufacturers & Partners 6/29/2023
    06/29/23 Biosimilar Development Newsletter
42. 06.22.23 -- 5 Characteristics Of The Automated Microbiology Lab Of The Future 6/22/2023
    06/22/23 Biosimilar Development Newsletter
43. 06.15.23 -- Pfizer, Samsung Biologics Announce Biosimilar Manufacturing Collaboration 6/15/2023
    06/15/23 Biosimilar Development Newsletter
44. 06.14.23 -- A New Vial Design Capable Of Curbing Delamination And Glass Particulate Generation 6/14/2023

    06/14/23 Biosimilar Development Newsletter

45. 06.09.23 -- Strategies To Streamline Combination Product Development For Biosimilars 6/9/2023

    06/09/23 Biosimilar Development Newsletter

46. 06.08.23 -- Mark Cuban, Coherus Team Up For Broader Humira Access 6/8/2023
    06/08/23 Biosimilar Development Newsletter
47. 06.07.23 -- Antibody Variants, Mechanistic Modeling, And High-Throughput Process Development 6/7/2023

    06/07/23 Biosimilar Development Newsletter

48. 06.05.23 -- Unlock The Potential Of Your Biopharmaceutical Development 6/5/2023

    06/05/23 Biosimilar Development Newsletter

49. 06.01.23 -- Risk-Based Strategies For Revalidating Bio/Pharma Equipment & Systems 6/1/2023
    06/01/23 Biosimilar Development Newsletter
50. 05.25.23 -- The Global Market For Biosimilars Through 2032 5/25/2023
    05/25/23 Biosimilar Development Newsletter